MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 10, 2008; DOI: 10.1124/mol.108.048447

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.048447v1
mol.108.048447v2    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Binda, F.
Right arrow Articles by Galli, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Binda, F.
Right arrow Articles by Galli, A.


Received for publication April 30, 2008.
Revised July 9, 2008.
Accepted for publication July 10, 2008.

Syntaxin1A Interaction with the Dopamine Transporter Promotes Amphetamine-Induced Dopamine Efflux

Francesca Binda 1, Concetta Dipace 1, Erica Bowton 1, Sabrina E Doughty 1, Brandon J Lute 1, Jacob U Fog 2, Minjia Zhang 3, Namita Sen 4, Roger J Colbran 1, Margaret E Gnegy 3, Ulrik Gether 2, Jonathan A Javitch 4, Kevin Erreger 1, Aurelio Galli 5*

1 Vanderbilt University 2 University of Copenhagen 3 University of Michigan 4 Columbia University 5 vanderbilt

* Address correspondence to: E-mail: aurelio.galli{at}vanderbilt.edu

Abstract

The SNARE protein syntaxin1A (SYN1A) interacts with and regulates the function of transmembrane proteins including ion channels and neurotransmitter transporters. Here we define the first 33 amino acids of the N-terminus of the dopamine (DA) transporter (DAT) as the site of direct interaction with SYN1A. Amphetamine (AMPH) increases the association of SYN1A with human DAT (hDAT) in a heterologous expression system (hDAT cells) and with native DAT in murine striatal synaptosomes. Immunoprecipitation of DAT from the biotinylated fraction shows that the AMPH-induced increase in DAT/SYN1A association occurs at the plasma membrane. In a superfusion assay of DA efflux, cells overexpressing SYN1A exhibited significantly greater AMPH-induced DA release with respect to control cells. By combining the patch clamp technique with amperometry we measured DA release under voltage clamp. At -60 mV, a physiological resting potential, AMPH did not induce DA efflux in hDAT cells and DA neurons. In contrast, perfusion of exogenous SYN1A (3 µM) into the cell with the whole-cell pipette enabled AMPH-induced DA efflux at -60 mV both in hDAT cells and DA neurons. Recently, it has been shown that Ca2+/calmodulin-dependent protein kinase II (CaMKII) is activated by AMPH and regulates AMPH-induced DA efflux. Here we show that AMPH-induced association between DAT and SYN1A requires CaMKII activity and that inhibition of CaMKII blocks the ability of exogenous SYN1A to promote DA efflux. These data suggest that AMPH activation of CaMKII supports DAT/SYN1A association, resulting in a mode of DAT capable of DA efflux.


Key words: Dopamine, Biogenic Amine, Amphetamines





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics